Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.09 USD | +1.76% | -7.44% | +24.46% |
Apr. 30 | RBC Lifts Price Target on Avid Bioservices to $8 From $7, Keeps Outperform Rating | MT |
Apr. 29 | Transcript : Avid Bioservices, Inc., Q3 2024 Earnings Call, Apr 29, 2024 |
Financials (USD)
Sales 2024 * | 139M | Sales 2025 * | 164M | Capitalization | 514M |
---|---|---|---|---|---|
Net income 2024 * | -20M | Net income 2025 * | -11M | EV / Sales 2024 * | 3.69 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 3.13 x |
P/E ratio 2024 * |
-25.5
x | P/E ratio 2025 * |
-43.1
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Avid Bioservices, Inc.
1 day | +1.76% | ||
1 week | -7.44% | ||
1 month | +5.48% | ||
3 months | -1.82% | ||
6 months | +61.96% | ||
Current year | +24.46% |
Managers | Title | Age | Since |
---|---|---|---|
Nicholas Green
CEO | Chief Executive Officer | 60 | 20-07-29 |
Daniel Hart
DFI | Director of Finance/CFO | 50 | 18-07-31 |
Nick Ferguson
CTO | Chief Tech/Sci/R&D Officer | - | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Sargen
BRD | Director/Board Member | 58 | 17-11-26 |
Joseph Carleone
CHM | Chairman | 78 | 17-11-26 |
Catherine Mackey
BRD | Director/Board Member | 68 | 19-07-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 8.09 | +1.76% | 714,699 |
24-05-30 | 7.95 | -0.25% | 752,015 |
24-05-29 | 7.97 | -7.54% | 632,324 |
24-05-28 | 8.62 | -1.37% | 476,952 |
24-05-24 | 8.74 | -1.02% | 388,724 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.46% | 514M | |
-2.29% | 89.87B | |
-3.95% | 37.57B | |
-13.07% | 32.75B | |
+63.05% | 26.47B | |
-22.14% | 14.25B | |
-7.96% | 12.99B | |
-9.33% | 11.93B | |
-46.33% | 10.84B | |
+5.77% | 9.11B |
- Stock Market
- Equities
- CDMO Stock